MedEquities Realty Trust (NYSE:MRT) will announce its earnings results after the market closes on Friday, November 9th. Analysts expect the company to announce earnings of $0.28 per share for the quarter.
MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.20). The firm had revenue of $17.56 million during the quarter, compared to the consensus estimate of $17.03 million. MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%. On average, analysts expect MedEquities Realty Trust to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
MRT opened at $8.34 on Friday. The company has a market capitalization of $267.96 million, a price-to-earnings ratio of 7.32 and a beta of -0.08. MedEquities Realty Trust has a 1-year low of $8.25 and a 1-year high of $12.04.
In related news, Director Bluemountain Capital Managemen sold 11,695 shares of the company’s stock in a transaction on Monday, October 29th. The shares were sold at an average price of $8.39, for a total transaction of $98,121.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders have sold 147,016 shares of company stock valued at $1,287,853. 2.50% of the stock is owned by company insiders.
A number of equities analysts have weighed in on MRT shares. Citigroup lowered shares of MedEquities Realty Trust from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $10.00 to $9.00 in a research report on Friday, September 14th. Canaccord Genuity dropped their price target on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, August 9th. B. Riley set a $12.00 price target on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research report on Thursday, August 9th. Zacks Investment Research lowered shares of MedEquities Realty Trust from a “hold” rating to a “strong sell” rating in a research report on Saturday, September 15th. Finally, ValuEngine lowered shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 8th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $11.25.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Featured Story: How to Use a Moving Average for Trading
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.